wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34484368-39BA2F7D-0241-47C8-9121-1AED4D6A0ADA
Q34484368-39BA2F7D-0241-47C8-9121-1AED4D6A0ADA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34484368-39BA2F7D-0241-47C8-9121-1AED4D6A0ADA
An open-label study to determine the maximum tolerated dose of the multitargeted tyrosine kinase inhibitor CEP-11981 in patients with advanced cancer.
P2860
Q34484368-39BA2F7D-0241-47C8-9121-1AED4D6A0ADA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34484368-39BA2F7D-0241-47C8-9121-1AED4D6A0ADA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fb7d51fe87d8583dfc4472e3a1b4bc67727aa6b8
P2860
Development of second-generation VEGFR tyrosine kinase inhibitors: current status.